SIA PrintyMed is a biotech startup specialising in the production of unique biomaterials, specifically artificial spider silk, for various medical applications. The company is focused on developing innovative solutions such as artificial organs and scaffolds derived from its artificial spider silk technology. Currently, SIA PrintyMed is dedicated to creating cell adhesion membranes for organ-on-chip solutions, aiming to enhance biomedical research and therapeutic development.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Development of cell adhesion membranes
– Research and development for artificial organs
– Production of scaffolds for tissue engineering

SIA PrintyMed is committed to advancing healthcare through its pioneering biomaterial solutions. To learn more about their innovative offerings, please visit printymed.com.